Anne Arundel Dermatology (PRIVATE.ANNEARUNDEL)

Overall impact
C (59)

Commentary

Anne Arundel Dermatology is an average overall performer. With a 'C' rating of 58.9 for overall impact (60th percentile compared to all companies), Anne Arundel Dermatology ranks 43rd out of 71 industry peers, behind ModivCare, Ontrak, Hanger and 39 others, and ahead of Bumrungrad Hospital, Rede D'Or São Luiz, Dr. Sulaiman Al Habib Medical Services Company and 25 others. On top material causes for Anne Arundel Dermatology's industry (Healthcare Providers), Anne Arundel Dermatology performs well in Disease Eradication (90.5 score), Access to Affordable Healthcare (95.5), Child and Maternal Health (94.5) and 2 other causes where it received an 'A' score and performs poorly in Free, Secure Flow of Information (26.7 score), Fair Labor Practices (4.3), Child and Maternal Health (36.9) and 4 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.ANNEARUNDEL
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1974
Employees
300
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
Maryland, United States
Share classes
PRIVATE.ANNEARUNDEL
Description
Operator of a chain of dermatology clinics intended to offer reliable skin care treatment. The company offers a comprehensive suite of dermatological services which includes general, skin, cosmetic, medical and pediatric dermatology as well as advanced treatment options for skin cancer and cosmetic procedures, enabling clients to meet their medical, surgical and aesthetic care needs.
Material causes
Ethos considers the following causes material for Anne Arundel Dermatology, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.